ALFA FinderBSE filing, NSE: TRIMURTHI. Summary written from the filing by ALFA Finder's alert engine.
Novelix Pharmaceuticals Ltd: key numbers
- Share price
- ₹69.49
- Market cap
- ₹122.4 Cr
- Revenue (annual)
- ₹132.3 Cr
- Net profit (annual)
- ₹2.56 Cr
- P/E (TTM)
- 26.3×Sector 65.7×
- Promoter holding
- 54.29%+3.72% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Novelix Pharmaceuticals Ltd
All →Novelix Pharmaceuticals Business Update
Novelix Pharmaceuticals entered a supply agreement with axabio NV, Belgium, to procure natural astaxanthin. No specific contract value was disclosed.
Novelix Pharmaceuticals Other Announcement
Novelix Pharmaceuticals reported no deviation in its July 2026 fund raise utilisation for the September quarter. This periodic statement records no new business event.
Novelix Pharmaceuticals Q2 FY27 Results: Net Profit ₹1.6 Cr, Up 220.0% YoY
Novelix Pharmaceuticals Ltd reported revenue from operations of ₹44.7 Cr (+22.8% YoY) and net profit of ₹1.6 Cr (+220.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.6 Cr · +220.0% YoY
Novelix Pharmaceuticals Board Meeting Date
Novelix Pharmaceuticals has given prior intimation of a board meeting on 11 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window stays closed until forty-eight hours after the meeting.
Novelix Pharmaceuticals Other Announcement
Novelix Pharmaceuticals Ltd has filed its quarterly shareholding pattern as per SEBI Regulation 31(1)(b) for the period ended September 30, 2026.
Novelix Pharmaceuticals Management Change
Novelix Pharmaceuticals announced the appointment of Mr. Gnana Prakash Gattu as Whole Time Director, approved by shareholders at the company's 32nd Annual General Meeting.
Other management change announcements
All →Saroja Pharma Industries India Management Change
Saroja Pharma's statutory auditor, Pravin Chandak & Associates, revised its resignation to be effective 15 November 2026. The auditor cites pre-occupation in other professional assignments as the reason.
Laffans Petrochemicals Management Change
Laffans Petrochemicals appointed Swapna Shivashankaran as Company Secretary and Compliance Officer, effective 16 November 2026. It also removed secretarial auditor V Kumar & Associates, effective 13 November 2026.
Ceinsys Tech Management Change
Ceinsys Tech appointed Bala Pavan Kumar Tsunduru as President & Senior Management, effective 2026-12-07. Also reports a KMP designation change for Richa Jain (CFO/Deputy CFO).
Zetwerk Manufacturing Businesses Management Change
Zetwerk Manufacturing Businesses replaced its Company Secretary and Compliance Officer. Mania Sarkar ceased from 13 November 2026 and Dhanraj Dagar was appointed from 14 November 2026.
Solve Plastic Products Management Change
Solve Plastic Products appointed CA Anju K Raju as Chief Financial Officer effective November 13, 2026, approved by the board that day. The filing carries her professional profile.
Shalimar Wires Industries Management Change
Shalimar Wires Industries' Company Secretary, Suresh Kumar Kejriwal, has resigned. Pramod Kumar Agrawal has been appointed Company Secretary and Compliance Officer.